icon
icon
icon
icon
Upgrade
Upgrade

News /

Articles /

EveryBaby, an Irish health-tech company, said it intends to IPO in Hong Kong in the form of 18A in the future.

Market IntelTuesday, Mar 4, 2025 6:30 am ET
1min read

Dabriel Choi, CEO of EveryBaby, a health-tech company from Ireland, revealed at a media luncheon that the company plans to raise funds later this year, selling 20% of its shares to digital and healthcare investors in the United States. The company is eyeing a Hong Kong IPO in the form of 18A (for biotech companies without profits or revenue), but no timetable has been set yet.EveryBaby specializes in preventing premature births through analyzing cervical tissue, and is currently wholly owned by Dabriel Choi. He works in London, while the Asia-Pacific headquarters is in Hong Kong, due to the city's strong medical infrastructure and strategic location to help penetrate the Chinese market. Additionally, EveryBaby is developing the Middle East market and has an office in the United Arab Emirates.The Hong Kong Investment Promotion Agency (InvestHK) today held the 2025 Women's Health and Technology Forum, bringing together outstanding representatives from the government, academia, and the private sector to explore the relationship between technology and women's health. The forum and its media events covered topics such as policy initiatives, clinical research, and ecosystem development, attracting key stakeholders interested in developing the healthcare sector in Hong Kong.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.